TABLE 4.
E. coli strains | ||
---|---|---|
Strain | Relevant genotype | Source or construction |
BL21(DE3) | F− ompT hsdS B(rB− mB−) gal dcm (DE3) | Novagen |
MS100 | xyl-5 mtl-1 galK2 rpsL31 Δ(gpt-proA)62 lacY1 tsx-33 supE44 thi-1 hisG4(Oc) argE3(Oc) araD139 thr-1 sulA211 dnaN + tnaA300::Tn10 | 28 |
MS101 | MS100: dnaN159 tnaA300::Tn10 | 28 |
AB1157 | xyl-5 mtl-1 galK2 rpsL31 kdgK51 lacY1 tsx-33 supE44 thi-1 leuB6 hisG4(Oc) mgl-51 argE3(Oc) rfbD1 proA2 ara-14 thr-1 qsr-9 qin-111 | CGSCa 46 |
MS119 | AB1157: dnaN+tnaA300::Tn10 | 19 |
MS120 | AB1157: dnaN159 tnaA300::Tn10 | 19 |
MS134 | AB1157: dnaN159 tnaA300::Tn10 ΔpolB::Ω | This work |
MS123 | AB1157: dnaN159 tnaA300::Tn10 Δ(dinB-yafN)::kan | 19 |
MS122 | AB1157: dnaN159 tnaA300::Tn10 ΔumuDC595::cat | 19 |
MS135 | AB1157: dnaN159 tnaA300::Tn10 ΔpolB::Ω Δ(dinB-yafN)::kan | This work |
MS136 | AB1157: dnaN159 tnaA300::Tn10 ΔpolB::Ω ΔumuDC595::cat | This work |
MS124 | AB1157: dnaN159 tnaA300::Tn10 Δ(dinB-yafN)::kan ΔumuDC595::cat | 19 |
MS137 | AB1157: dnaN159 tnaA300::Tn10 ΔpolB::Ω Δ(dinB-yafN)::kan ΔumuDC595::cat | This work |
MS138 | AB1157: dnaN+-tet-recF+ | This work |
MS139 | AB1157: lamB::(His6-dnaN+-cat) | This work |
MS140 | AB1157: ΔpolB::Ω Δ(dinB-yafN)::kan | This work |
MS141 | AB1157: ΔpolB::Ω Δ(dinB-yafN)::kan lamB::(His6-dnaN+-cat) | This work |
MS142 | AB1157: ΔpolB::Ω Δ(dinB-yafN)::kan lamB::(His6-dnaN+-cat) dnaN+-tet-recF+ | This work |
MS143 | AB1157: ΔpolB::Ω Δ(dinB-yafN)::kan lamB::(His6-dnaN+-cat) dnaN148–152-tet-recF+ | This work |
MS144 | AB1157: ΔpolB::Ω Δ(dinB-yafN)::kan dnaN+-tet-recF+ (pJD100) | This work |
MS145 | AB1157: ΔpolB::Ω Δ(dinB-yafN)::kan dnaN148–152-tet-recF+ (pJD100) | This work |
Plasmid DNAs | ||
Plasmid | Relevant features | Source or construction |
pET11a | AmpR, ColE1 origin, directs overexpression of cloned gene under control of a T7 promoter | Novagen |
pET11a-β5A | AmpR, pET11a derivative overexpressing β148–152 from the T7 promoter | This work |
pβHMK | AmpR, pET16b derivative overexpressing β+ with an N-terminal His6 and kinase tag | 47 |
pβ5AHMK | AmpR, pβHMK derivative overexpressing β148–152 | This work |
pSU38 | KanR, p15A origin, cloning vector | 48 |
pACYCdnaN+ | KanR, pSU38 derivative expressing physiological levels of β+ | 19 |
pACMβ5A | KanR, pSU38 derivative expressing physiological levels β148–152 | 19 |
pACM | CamR, pSU38 derivative containing the cat gene inserted in kan | 19 |
pACMdnaN+ | CamR, pACM derivative expressing physiological levels of β+ | 19 |
pACMβ5A | CamR, pACM derivative expressing physiological levels of β148–152 | 19 |
pAMP | AmpR, pSU38 derivative containing the bla gene inserted in kan | 19 |
pAMPdnaN+ | AmpR, pAMP derivative expressing physiological levels of β+ | 19 |
pAMPβ5A | AmpR, pAMP derivative expressing physiological levels of β148–152 | 19 |
pRD46 | AmpR, pSC101 origin, repA(Ts), expresses λ Red recombinase function under control of araBADC promoter | 27 |
pAB1 | TetR, pBR322 derivative containing 7.8-kbp PstIdnaA71 (Cs, Sx) dnaN+recF +gyrB + cassette | 49 |
pANTF | KanR TetR, pACYCdnaN+ derivative containing dnaA+-dnaN+-tet-recF+ cassette | This work |
pANβ5TF | KanR TetR, pANTF derivative containing dnaA+-dnaN148–152-tet-recF+ cassette | This work |
pANβ5PVUIITF | KanR TetR, pANβ5TF derivative containing a copy of the dnaA+-dnaN148–152-tet-recF+ cassette with a silent mutation within dnaN148–152 that disrupts a PvuII restriction site | This work |
pRMB100-Cat | KanR CamR, pSU38 derivative containing lamB::(His6-dnaN+-cat) cassette | This work |
pWSK29 | AmpR, pSC101 origin, low copy number cloning vector | 50 |
pJD100 | AmpR, pSC101 origin, expresses physiological levels of dnaN+ | 28 |
pKOV | CamR, pSC101 origin, repA(Ts) | 45 |
Oligonucleotides | ||
Primer | Nucleotide sequence | |
80-mer | 5′–[T30]CTCCCTTCTTCTCCTCCCTCTCCCTTCCC[T21]-Biotin–3′ | |
30-mer | 5′–AGGGAAGGGAGAGGGAGGAGAAGAAGGGAG–3′ | |
SP20 | 5′–ACGCCTGTAGCATTCCACAG–3′ | |
D150 loop top | 5′–CTATGGCGGCTGCGGCCGCTGCCTATTACTAAATGG–3′ | |
D150 loop bottom | 5′–CCATTTAAGTAATAGGCAGCGGCCGCAGCCGCCATAG–3′ | |
Tet top | 5′–GCACCTCGAGTCAGCCCCATA–3′ | |
Tet bottom | 5′–GAGTGGTGAATTCGTTAGCG–3′ | |
RecF top | 5′–GAGCGCGAATTCTGTTGTCATGCC–3′ | |
RecF bottom | 5′–CAACGTTTCTCGAGCATTTATACTTGG–3′ | |
D150ΔPvuII top | 5′–CGTGCAACTAGAAGGTGAACGGATGCTGGTACGCTCCGG–3′ | |
D150ΔPvuII bottom | 5′–CCGGAGCGTACCAGCATCCGTTCACCTTCTAGTTGCACG–3′ | |
JK28+2 | 5′–CATTGCCAATGCCAACTTTACC–3′ | |
RecF back | 5′–CTTCGAATTTTCGTCCGACATGTC–3′ | |
DnaAP | 5′–CATGAATGTTTCAGCCTTAGTC–3′ | |
LamB-1 | 5′–CTCGCGCAAACTTCCTCTGGCGGTTGCCG–3′ | |
LamB-2 | 5′–GAGACAAAGCTTGAGACGCGTGAGGTCGACGAGGGGTTGATTTCCATCTGCGCTAAACGCACATCG–3′ | |
LamB-7 | 5′–GAGACAACGCGTGAGGGATCCACACGTGCCAACTTGCGTGATAACTATCGTCTGG–3′ | |
LamB-8 | 5′–AGTGCCAAGCTTGAGCCATCTGGGCACCGAAGGTCCACTCGTC–3′ | |
Cat promoter | 5′–GAATTCGGATCCGTCTGCTATGTGGTGCTAT–3′ | |
Cat end | 5′–GAATTCGGATCCCTTATTCAGGCGTAGCACCAGGCG–3′ | |
LamB-DN | 5′–GAATGCGGCGTAAACGCCTTATCC–3′ |
CGSC, E. coli Genetic Stock Center, Yale University, New Haven CT, USA.